FVIFX | JVMCX | FVIFX / JVMCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 21 years | 14 years | - |
Gain YTD | -0.713 | 1.937 | -37% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 373M | 22.5B | 2% |
Annual Yield % from dividends | 0.96 | 0.01 | 6,774% |
Returns for 1 year | -2.87 | -3.41 | 84% |
Returns for 3 years | 10.77 | 0.68 | 1,585% |
Returns for 5 years | 54.26 | 19.69 | 275% |
Returns for 10 years | 58.77 | 25.70 | 229% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PHLAX | 35.05 | -0.19 | -0.54% |
PGIM Jennison Health Sciences A | |||
NUGIX | 35.31 | -0.31 | -0.87% |
Nuveen Global Dividend Growth I | |||
TRGIX | 15.82 | -0.33 | -2.04% |
Nuveen Core Equity Retire | |||
BPSIX | 26.20 | -0.57 | -2.13% |
Boston Partners Small Cap Value II I | |||
FMEFX | 40.76 | -1.82 | -4.27% |
Nuveen Mid Cap Growth Opps R6 |